APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fully MagLev Ventricular Assist Device (VAD)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fully MagLev Ventricular Assist Device (VAD) Market Outlook and Growth Opportunities 2026

25 December 2025194 pages

Choose your research edition.

Industry ResearchFully MagLev Ventricular Assist Device (VAD) Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Fully MagLev Ventricular Assist Device (VAD) Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Fully MagLev Ventricular Assist Device (VAD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fully MagLev Ventricular Assist Device (VAD) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Fully MagLev Ventricular Assist Device (VAD) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Fully MagLev Ventricular Assist Device (VAD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fully MagLev Ventricular Assist Device (VAD) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fully MagLev Ventricular Assist Device (VAD) market include BiVACOR, Shenzhen Core Medical Technology, Suzhou Tongxin Medical Devices and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fully MagLev Ventricular Assist Device (VAD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fully MagLev Ventricular Assist Device (VAD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fully MagLev Ventricular Assist Device (VAD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fully MagLev Ventricular Assist Device (VAD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Fully MagLev Ventricular Assist Device (VAD) Segment by Company

BiVACOR

Shenzhen Core Medical Technology

Suzhou Tongxin Medical Devices

Abbott

Fully MagLev Ventricular Assist Device (VAD) Segment by Type

Left Ventricular Assist Device (LVAD)

Biventricular Assist Device (BiVAD)

Fully MagLev Ventricular Assist Device (VAD) Segment by Application

Bridge-to-transplant (BTT)

Destination Therapy (DT)

Others

Fully MagLev Ventricular Assist Device (VAD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fully MagLev Ventricular Assist Device (VAD) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fully MagLev Ventricular Assist Device (VAD) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fully MagLev Ventricular Assist Device (VAD) significant trends, drivers, influence factors in global and regions.

6. To analyze Fully MagLev Ventricular Assist Device (VAD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fully MagLev Ventricular Assist Device (VAD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fully MagLev Ventricular Assist Device (VAD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fully MagLev Ventricular Assist Device (VAD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fully MagLev Ventricular Assist Device (VAD) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fully MagLev Ventricular Assist Device (VAD) industry.

Chapter 3: Detailed analysis of Fully MagLev Ventricular Assist Device (VAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fully MagLev Ventricular Assist Device (VAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fully MagLev Ventricular Assist Device (VAD) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fully MagLev Ventricular Assist Device (VAD) Industry Trends Table 2. Fully MagLev Ventricular Assist Device (VAD) Industry Drivers Table 3. Fully MagLev Ventricular Assist Device (VAD) Industry Opportunities and Challenges Table 4. Fully MagLev Ventricular Assist Device (VAD) Industry Restraints Table 5. Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fully MagLev Ventricular Assist Device (VAD) Revenue Share by Company (2021-2026) Table 7. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Company (Units) & (2021-2026) Table 8. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Company (2021-2026) Table 9. Global Fully MagLev Ventricular Assist Device (VAD) Average Price (K US$/Unit) of Company (2021-2026) Table 10. Global Fully MagLev Ventricular Assist Device (VAD) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fully MagLev Ventricular Assist Device (VAD) Key Company Manufacturing Base & Headquarters Table 12. Global Fully MagLev Ventricular Assist Device (VAD) Company, Product Type & Application Table 13. Global Fully MagLev Ventricular Assist Device (VAD) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fully MagLev Ventricular Assist Device (VAD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Left Ventricular Assist Device (LVAD) Table 18. Significant Companies of Biventricular Assist Device (BiVAD) Table 19. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Type (2021-2026) & (Units) Table 21. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Type (2027-2032) & (Units) Table 22. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Type (2021-2026) Table 23. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Type (2027-2032) Table 24. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type (2021-2026) Table 28. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Bridge-to-transplant (BTT) Table 30. Significant Companies of Destination Therapy (DT) Table 31. Significant Companies of Others Table 32. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Application (2021-2026) & (Units) Table 34. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Application (2027-2032) & (Units) Table 35. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Application (2021-2026) Table 36. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Application (2027-2032) Table 37. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application (2021-2026) Table 41. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application (2027-2032) Table 42. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2021-2026) & (Units) Table 44. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Region (2021-2026) Table 45. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2027-2032) & (Units) Table 46. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Region (2027-2032) Table 47. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Region (2021-2026) Table 50. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Region (2027-2032) Table 52. Global Fully MagLev Ventricular Assist Device (VAD) Market Average Price (K US$/Unit) by Region (2021-2026) Table 53. Global Fully MagLev Ventricular Assist Device (VAD) Market Average Price (K US$/Unit) by Region (2027-2032) Table 54. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2026) & (Units) Table 57. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Country (2021-2026) Table 58. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2027-2032) & (Units) Table 59. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Country (2027-2032) Table 60. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Market Share by Country (2021-2026) Table 62. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Market Share by Country (2027-2032) Table 64. BiVACOR Company Information Table 65. BiVACOR Business Overview Table 66. BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 67. BiVACOR Fully MagLev Ventricular Assist Device (VAD) Product Portfolio Table 68. BiVACOR Recent Development Table 69. Shenzhen Core Medical Technology Company Information Table 70. Shenzhen Core Medical Technology Business Overview Table 71. Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 72. Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Product Portfolio Table 73. Shenzhen Core Medical Technology Recent Development Table 74. Suzhou Tongxin Medical Devices Company Information Table 75. Suzhou Tongxin Medical Devices Business Overview Table 76. Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 77. Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Product Portfolio Table 78. Suzhou Tongxin Medical Devices Recent Development Table 79. Abbott Company Information Table 80. Abbott Business Overview Table 81. Abbott Fully MagLev Ventricular Assist Device (VAD) Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 82. Abbott Fully MagLev Ventricular Assist Device (VAD) Product Portfolio Table 83. Abbott Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Fully MagLev Ventricular Assist Device (VAD) Distributors List Table 87. Fully MagLev Ventricular Assist Device (VAD) Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Fully MagLev Ventricular Assist Device (VAD) Product Image Figure 2. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fully MagLev Ventricular Assist Device (VAD) Sales (2021-2032) & (Units) Figure 5. Global Fully MagLev Ventricular Assist Device (VAD) Sales Average Price (K US$/Unit) & (2021-2032) Figure 6. Global Fully MagLev Ventricular Assist Device (VAD) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Left Ventricular Assist Device (LVAD) Image Figure 10. Biventricular Assist Device (BiVAD) Image Figure 11. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Type (2021-2032) Figure 14. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type (2021-2032) Figure 17. Bridge-to-transplant (BTT) Image Figure 18. Destination Therapy (DT) Image Figure 19. Others Image Figure 20. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Application (2021-2032) Figure 23. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application (2021-2032) Figure 26. Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Fully MagLev Ventricular Assist Device (VAD) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Fully MagLev Ventricular Assist Device (VAD) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Left Ventricular Assist Device (LVAD)
  • Biventricular Assist Device (BiVAD)
Applications
  • Bridge-to-transplant (BTT)
  • Destination Therapy (DT)
  • Others
Companies covered
  • BiVACOR
  • Shenzhen Core Medical Technology
  • Suzhou Tongxin Medical Devices
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032)
  4. 1.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume (2021-2032)
  5. 1.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fully MagLev Ventricular Assist Device (VAD) Market Dynamics
  1. 2.1 Fully MagLev Ventricular Assist Device (VAD) Industry Trends
  2. 2.2 Fully MagLev Ventricular Assist Device (VAD) Industry Drivers
  3. 2.3 Fully MagLev Ventricular Assist Device (VAD) Industry Opportunities and Challenges
  4. 2.4 Fully MagLev Ventricular Assist Device (VAD) Industry Restraints
3 Fully MagLev Ventricular Assist Device (VAD) Market by Company
  1. 3.1 Global Fully MagLev Ventricular Assist Device (VAD) Company Revenue Ranking in 2025
  2. 3.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Company (2021-2026)
  3. 3.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Company (2021-2026)
  4. 3.4 Global Fully MagLev Ventricular Assist Device (VAD) Average Price by Company (2021-2026)
  5. 3.5 Global Fully MagLev Ventricular Assist Device (VAD) Company Ranking (2024-2026)
  6. 3.6 Global Fully MagLev Ventricular Assist Device (VAD) Company Manufacturing Base and Headquarters
  7. 3.7 Global Fully MagLev Ventricular Assist Device (VAD) Company Product Type and Application
  8. 3.8 Global Fully MagLev Ventricular Assist Device (VAD) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fully MagLev Ventricular Assist Device (VAD) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fully MagLev Ventricular Assist Device (VAD) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fully MagLev Ventricular Assist Device (VAD) Market by Type
  1. 4.1 Fully MagLev Ventricular Assist Device (VAD) Type Introduction
  2. 4.1.1 Left Ventricular Assist Device (LVAD)
  3. 4.1.2 Biventricular Assist Device (BiVAD)
  4. 4.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Type
  5. 4.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Type
  9. 4.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type (2021-2032)
5 Fully MagLev Ventricular Assist Device (VAD) Market by Application
  1. 5.1 Fully MagLev Ventricular Assist Device (VAD) Application Introduction
  2. 5.1.1 Bridge-to-transplant (BTT)
  3. 5.1.2 Destination Therapy (DT)
  4. 5.1.3 Others
  5. 5.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Application
  6. 5.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Application
  10. 5.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application (2021-2032)
6 Fully MagLev Ventricular Assist Device (VAD) Regional Sales and Value Analysis
  1. 6.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2021-2032)
  3. 6.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region: 2021-2026
  4. 6.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2027-2032)
  5. 6.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Region (2027-2032)
  9. 6.5 Global Fully MagLev Ventricular Assist Device (VAD) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032)
  12. 6.6.2 North America Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032)
  15. 6.7.2 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032)
  21. 6.9.2 South America Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Country, 2025 VS 2032
7 Fully MagLev Ventricular Assist Device (VAD) Country-level Sales and Value Analysis
  1. 7.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2032)
  4. 7.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2026)
  5. 7.3.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2027-2032)
  6. 7.4 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fully MagLev Ventricular Assist Device (VAD) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fully MagLev Ventricular Assist Device (VAD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BiVACOR
  2. 8.1.1 BiVACOR Company Information
  3. 8.1.2 BiVACOR Business Overview
  4. 8.1.3 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
  6. 8.1.5 BiVACOR Recent Developments
  7. 8.2 Shenzhen Core Medical Technology
  8. 8.2.1 Shenzhen Core Medical Technology Company Information
  9. 8.2.2 Shenzhen Core Medical Technology Business Overview
  10. 8.2.3 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
  12. 8.2.5 Shenzhen Core Medical Technology Recent Developments
  13. 8.3 Suzhou Tongxin Medical Devices
  14. 8.3.1 Suzhou Tongxin Medical Devices Company Information
  15. 8.3.2 Suzhou Tongxin Medical Devices Business Overview
  16. 8.3.3 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
  18. 8.3.5 Suzhou Tongxin Medical Devices Recent Developments
  19. 8.4 Abbott
  20. 8.4.1 Abbott Company Information
  21. 8.4.2 Abbott Business Overview
  22. 8.4.3 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
  24. 8.4.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fully MagLev Ventricular Assist Device (VAD) Value Chain Analysis
  2. 9.1.1 Fully MagLev Ventricular Assist Device (VAD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fully MagLev Ventricular Assist Device (VAD) Sales Mode & Process
  6. 9.2 Fully MagLev Ventricular Assist Device (VAD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fully MagLev Ventricular Assist Device (VAD) Distributors
  9. 9.2.3 Fully MagLev Ventricular Assist Device (VAD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst